Quality of Life in Patients With Severe Skin Reactions in Course of First-Generation Epidermal Growth Factor Receptor Inhibitors Monoclonal Antibodies (Our Experience With Cetuximab)

BACKGROUND: Metastatic colorectal cancer (mCRC) with wild type expression of RAS and RAF genes can be treated with anti-epidermal growth factor receptor (EGFR) monoclonal antibodies, such as cetuximab, in combination with chemotherapy. Skin toxicity represents the most serious and frequent side effe...

Descripción completa

Detalles Bibliográficos
Autores principales: De Luca, Rossella, Lo Coco, Gianluca, Addeo, Raffaele, Fattoruso, Silvia Ileana Sara, Auriemma, Annunziata, Paci, Roberta, Mistretta, Ornella, Epifanio, Maria Stella, Salvato, Angela, D’Agostino, Alberto, Cicero, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297050/
https://www.ncbi.nlm.nih.gov/pubmed/34349854
http://dx.doi.org/10.14740/wjon1381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297050/
https://www.ncbi.nlm.nih.gov/pubmed/34349854
http://dx.doi.org/10.14740/wjon1381

Ejemplares similares